BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17075480)

  • 1. [Hereditary diffuse gastric cancer].
    Sezeur A; Schielke A; Larue L; Fléjou JF
    Gastroenterol Clin Biol; 2006 Oct; 30(10):1205-13. PubMed ID: 17075480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary gastric cancer.
    Carneiro F
    Pathologe; 2012 Nov; 33 Suppl 2():231-4. PubMed ID: 23052347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
    de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series.
    Gjyshi O; Vashi P; Seewald L; Kohan M; Abboud E; Fowler E; Suppiah R; Halabi H
    World J Surg Oncol; 2018 Jul; 16(1):143. PubMed ID: 30007404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
    Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
    Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hereditary diffuse gastric cancer].
    Melo Pezo X; Medrano Samamé H; Torres Rosas E
    Rev Gastroenterol Peru; 2015 Jan; 35(1):73-8. PubMed ID: 25875520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
    Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
    N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary diffuse gastric cancer: surgery, surveillance and unanswered questions.
    Cisco RM; Norton JA
    Future Oncol; 2008 Aug; 4(4):553-9. PubMed ID: 18684065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case n(o) 6: Signet ring cell intramucosal carcinoma in hereditary diffuse gastric cancer with mutated CDH1 gene].
    Svrcek M
    Ann Pathol; 2011 Oct; 31(5):381-4. PubMed ID: 21982246
    [No Abstract]   [Full Text] [Related]  

  • 10. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
    Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
    Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
    Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
    Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.
    Guilford P; Humar B; Blair V
    Gastric Cancer; 2010 Mar; 13(1):1-10. PubMed ID: 20373070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members.
    Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
    Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
    Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
    Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
    Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of pathology in the identification of hereditary diffuse gastric cancer: report of a Portuguese family.
    Oliveira C; Moreira H; Seruca R; de Oliveira MC; Carneiro F
    Virchows Arch; 2005 Feb; 446(2):181-4. PubMed ID: 15735979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients.
    Strong VE; Gholami S; Shah MA; Tang LH; Janjigian YY; Schattner M; Selby LV; Yoon SS; Salo-Mullen E; Stadler ZK; Kelsen D; Brennan MF; Coit DG
    Ann Surg; 2017 Dec; 266(6):1006-1012. PubMed ID: 27759617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary Diffuse Gastric Cancer Treated by Prophylactic Total Gastrectomy.
    Inaba Y; Goda K; Kondo M; Abe K; Kanamori A; Suzuki T; Tominaga K; Nakagawa M; Morita S; Kojima K; Ishida K; Irisawa A
    Intern Med; 2024 Jan; 63(2):235-239. PubMed ID: 37225495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice?
    Zhang Q; Yang Z; Karamchandani DM
    Ann Diagn Pathol; 2020 Apr; 45():151473. PubMed ID: 31986421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?
    Shaw D; Blair V; Framp A; Harawira P; McLeod M; Guilford P; Parry S; Charlton A; Martin I
    Gut; 2005 Apr; 54(4):461-8. PubMed ID: 15753528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.